Identification of time point to best define ‘ sub-optimal response ’ following intravitreal ranibizumab therapy for diabetic macular edema based on real-life data

Identification of time point to best define ‘sub-optimal response’ following intravitreal ranibizumab therapy for diabetic macular edema based on real-life data Eye advance online publication, June 16 2017. doi:10.1038/eye.2017.111 Authors: I Chatziralli, M Santarelli, N Patrao, L Nicholson, M Zola, R Rajendram, P Hykin & S Sivaprasad
Source: Eye - Category: Opthalmology Authors: Source Type: research